Activities per year
Activities
The Alzheimer's Paradox: Adcancing Criteria but Failing in Clinical Trials - What to Expect from the future
Philip Scheltens (Speaker)23 Jan 2020
Activity: Talk or presentation › Invited talk
The prospects for the development of a comprehensive view of nerve impulse propagation
Benjamin Drukarch (Speaker)15 Apr 2019
Activity: Talk or presentation › Invited talk
Amyloid PET daily practice experience in the Netherlands
Philip Scheltens (Speaker)26 Oct 2019
Activity: Talk or presentation › Invited talk
Sociale cognitie vanuit (neuro) psychiatrisch perspectief
Annemieke Dols (Speaker)8 Nov 2019
Activity: Talk or presentation › Invited talk
Op en neer, ouder worden met een bipolaire stoornis
Annemieke Dols (Speaker)14 Nov 2019
Activity: Talk or presentation › Invited talk
The future of Alzheimer Diagnosis: the basis for therapy
Philip Scheltens (Speaker)9 Nov 2019
Activity: Talk or presentation › Invited talk
Absence of tissue transglutaminase delays amyloid-beta deposition in an Alzheimer’s disease mouse model
Micha Wilhelmus (Invited speaker)17 Mar 2019
Activity: Talk or presentation › Invited talk
The design of a serious game in CPT education
Micha Wilhelmus (Keynote speaker)8 Sep 2018
Activity: Talk or presentation › Invited talk
Neuropsychiatric symptoms in FTD: The missing link?
Annemieke Dols (Speaker)10 Nov 2018
Activity: Talk or presentation › Invited talk
absence of tissue transglutaminase delays amyloid-beta deposition in alzheimer's disease
Benjamin Drukarch (Speaker)Jun 2018
Activity: Talk or presentation › Invited talk
Changes in autophagy in the Parkinsonian brain
Wilma van de Berg (Speaker)6 Nov 2017
Activity: Talk or presentation › Invited talk
ZOOMING IN ON THE ARCHITECTURE OF LEWY PATHOLOGY IN DIFFERENT REGIONS OF THE PARKINSON’S DISEASE BRAIN
T. Moors (Speaker), Christina Maat (Speaker), Wilma van de Berg (Speaker)8 Sep 2017
Activity: Talk or presentation › Invited talk
A 3D nanoview on Lewy body pathology using stimulated depletion and electron microscopy
Wilma van de Berg (Speaker)21 Mar 2017
Activity: Talk or presentation › Invited talk
Pathologie van Alzheimer: nieuwe inzichten?
Baayla Boon (Speaker)23 Mar 2017
Activity: Talk or presentation › Invited talk
Postmortem imaging in Neurodegenerative disorders: from macroscale to nanoscale
Wilma van de Berg (Speaker)6 Jan 2017
Activity: Talk or presentation › Invited talk
Characterization of α-synuclein Antibodies: Immunoreactivity on Human Postmortem Brain Tissue
Wilma van de Berg (Speaker)28 Mar 2017
Activity: Talk or presentation › Invited talk
CSF diagnostic and prognostic biomarkers in Parkinson’s disease and Dementia with Lewy bodies
Wilma van de Berg (Speaker)31 Jan 2017
Activity: Talk or presentation › Invited talk
Zooming into Parkinson’s and Alzheimer’s disease lesions in the human postmortem brain: from macroscale to nanoscale
Wilma van de Berg (Speaker)21 Nov 2017
Activity: Talk or presentation › Invited talk
Een reis door het verouderende brein
Wilma van de Berg (Speaker)17 Jan 2017
Activity: Talk or presentation › Invited talk
De ziekte van Parkinson
Odile van den Heuvel (Speaker)5 Oct 2017
Activity: Talk or presentation › Invited talk
Frontaal syndroom.
Annemieke Dols (Speaker), YAL Pijnenburg (Speaker)2017
Activity: Talk or presentation › Invited talk
Changes in mTOR signaling in the Parkinsonian brain
Wilma van de Berg (Speaker)28 Sep 2017
Activity: Talk or presentation › Invited talk
A 3D nanoview on Lewy body pathology in Parkinson's disease
Wilma van de Berg (Speaker)8 Aug 2017
Activity: Talk or presentation › Invited talk
Using the Alzheimer’s disease-mimicking APP23 mouse model to elucidate whether tissue transglutaminase is a therapeutic target in Alzheimer’s disease
Micha Wilhelmus (Invited speaker)15 Jul 2017
Activity: Talk or presentation › Invited talk
Cross-disease analysis of alpha-synuclein pathology using novel antibodies against post-translational modifications of alpha-synuclein
Christina Maat (Speaker), TE Moors (Speaker), Wilma van de Berg (Speaker)11 Aug 2017
Activity: Talk or presentation › Invited talk
development of PET tracers for imaging of active tissue transglutaminase
Benjamin Drukarch (Speaker)Jul 2016
Activity: Talk or presentation › Invited talk
Tissue transglutaminase in Alzheimer's disease.
Micha Wilhelmus (Invited speaker)Aug 2016
Activity: Talk or presentation › Invited talk
development of PET labels for imaging of tissue tranglutaminase activity in vivo
Benjamin Drukarch (Speaker)Jul 2015
Activity: Talk or presentation › Invited talk
Tissue transglutaminase: an attractive therapeutic target in Alzheimer's disease?
Micha Wilhelmus (Invited speaker)30 Jun 2015
Activity: Talk or presentation › Invited talk
Protein misfolding in neurodegenerative diseases: a common denominator
Micha Wilhelmus (Invited speaker)Sep 2014 → Dec 2014
Activity: Talk or presentation › Invited talk
Tissue transglutaminase: a potential therapeutic target in Alzheimer’s disease
Micha Wilhelmus (Invited speaker)Sep 2014 → Dec 2014
Activity: Talk or presentation › Invited talk
Impaired clearance of amyloid-beta in Alzheimer’s disease: targets for pharmacological intervention.
Micha Wilhelmus (Invited speaker)Sep 2014 → Dec 2014
Activity: Talk or presentation › Invited talk
Tissue transglutanminase: an potential target for Alzheimer’s disease overlooked
Micha Wilhelmus (Invited speaker)11 Oct 2013
Activity: Talk or presentation › Invited talk
Tissue transglutaminase: a novel therapeutic target for cerebral amyloid angiopathy.
Micha Wilhelmus (Invited speaker)Nov 2012
Activity: Talk or presentation › Invited talk
Tissue transglutaminase in Alzheimer’s disease pathology
Micha Wilhelmus (Invited speaker)May 2011
Activity: Talk or presentation › Invited talk
Role of tissue transglutaminase in cerebral amyloid angiopathy in Alzheimer’s disease.
Micha Wilhelmus (Invited speaker)Nov 2011
Activity: Talk or presentation › Invited talk
tissue transglutaminase and alpha-synuclein aggregation in parkinson's disease
Benjamin Drukarch (Speaker)Jul 2010
Activity: Talk or presentation › Invited talk
Transglutaminases in Alzheimer’s disease: a link between posttranslational protein modification and the aggregation cascade
Micha Wilhelmus (Invited speaker)Oct 2009
Activity: Talk or presentation › Invited talk
Protein aggregation in Alzheimer’s disease
Micha Wilhelmus (Speaker)Jan 2009
Activity: Talk or presentation › Invited talk
are-Nrf2 signaling as a target for neuroprotection in neurodegenerative diseases
Benjamin Drukarch (Speaker)Mar 2007
Activity: Talk or presentation › Invited talk
The 6th Dutch Endo-Neuro-Psycho meeting (2007), Doornwerth, The Netherlands
Micha Wilhelmus (Speaker)2007
Activity: Talk or presentation › Invited talk
tissue transglutaminase mediated aggregation of synuclein in parkinson's disease
Benjamin Drukarch (Speaker)Oct 2006
Activity: Talk or presentation › Invited talk
phase 2 detoxification enzymes as targets for neuroprotection in parkinson's disease
Benjamin Drukarch (Speaker)Mar 2005
Activity: Talk or presentation › Invited talk
de ontwikkeling van neuroprotectieva voor de ziekte van parkinson
Benjamin Drukarch (Speaker)Dec 2003
Activity: Talk or presentation › Invited talk
fase 2 detoxificatie enzymen als target voor de ontwikkeling van neuroprotectieva voor de ziekte van parkinson
Benjamin Drukarch (Speaker)Jan 2002
Activity: Talk or presentation › Invited talk
dopamine, neuromelanin and oxidative stress in parkinson's disease
Benjamin Drukarch (Speaker)Jun 2000
Activity: Talk or presentation › Invited talk
drug therapy of parkinson's disease: time for phase II
Benjamin Drukarch (Speaker)Oct 2000
Activity: Talk or presentation › Invited talk
astroglial protection of dopaminergic neurons against reactive oxygen species
Benjamin Drukarch (Speaker)Jul 1998
Activity: Talk or presentation › Invited talk
dopamine and glutathione in parkinson's disease
Benjamin Drukarch (Speaker)Jun 1996
Activity: Talk or presentation › Invited talk
hydrogen peroxide and neuronal signaling
Benjamin Drukarch (Speaker)Sep 1995
Activity: Talk or presentation › Invited talk